MetLife Investment Management, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,153,090
+22.4%
42,3230.0%0.01%
+28.6%
Q2 2023$941,687
-7.7%
42,323
-10.1%
0.01%
-12.5%
Q1 2023$1,020,164
+6.6%
47,0990.0%0.01%0.0%
Q4 2022$956,581
-20.8%
47,0990.0%0.01%
-20.0%
Q3 2022$1,207,618
+7.8%
47,0990.0%0.01%
+11.1%
Q2 2022$1,120,014
+5.6%
47,0990.0%0.01%
+28.6%
Q1 2022$1,060,669
+58.3%
47,099
+39.1%
0.01%
+16.7%
Q4 2021$670,210
+0.6%
33,8490.0%0.01%0.0%
Q3 2021$666,148
-23.1%
33,849
-14.1%
0.01%
-25.0%
Q2 2021$866,448
-7.5%
39,3840.0%0.01%
-11.1%
Q1 2021$936,945
-9.1%
39,3840.0%0.01%
-10.0%
Q4 2020$1,030,285
+36.2%
39,384
-9.3%
0.01%
+25.0%
Q3 2020$756,178
+3.5%
43,4460.0%0.01%0.0%
Q2 2020$730,762
+41.5%
43,4460.0%0.01%
+14.3%
Q1 2020$516,573
-1.7%
43,4460.0%0.01%
+40.0%
Q4 2019$525,697
-14.4%
43,4460.0%0.01%
-28.6%
Q3 2019$614,109
+26.8%
43,4460.0%0.01%
+40.0%
Q2 2019$484,423
-5.0%
43,4460.0%0.01%
-16.7%
Q1 2019$510,056
-12.1%
43,4460.0%0.01%
-14.3%
Q4 2018$580,439
-4.7%
43,4460.0%0.01%
+16.7%
Q3 2018$609,113
-10.8%
43,4460.0%0.01%
-25.0%
Q2 2018$683,000
-4.5%
43,4460.0%0.01%0.0%
Q1 2018$715,000
-8.9%
43,4460.0%0.01%
-11.1%
Q4 2017$785,00043,4460.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders